Cargando…
Chimeric Oncolytic Adenovirus Armed Chemokine Rantes for Treatment of Breast Cancer
The immunosuppressive state in the tumor microenvironment (TME) of breast cancer makes it difficult to treat with immunotherapy. Oncolytic viruses not only lyse tumor cells but also reshape the TME. Therefore, they can play a multi-mechanism synergistic effect with immunotherapy. In this study, an o...
Autores principales: | Ang, Lin, Li, Jiang, Dong, Hui, Wang, Chunhong, Huang, Jin, Li, Mingcong, Zhao, Min, Su, Changqing, Wu, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332706/ https://www.ncbi.nlm.nih.gov/pubmed/35892755 http://dx.doi.org/10.3390/bioengineering9080342 |
Ejemplares similares
-
Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors
por: Su, Yinghan, et al.
Publicado: (2022) -
The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma
por: LI, JIANG, et al.
Publicado: (2012) -
"Arming" the chimeric oncolytic adenovirus enadenotucirev to deliver checkpoint inhibitors and other therapeutics directly to tumours
por: Champion, Brian R, et al.
Publicado: (2014) -
The CC chemokine RANTES as a potential contributor to breast cancer progression
por: Azenshtein, E, et al.
Publicado: (2001) -
The Involvement of the Chemokine RANTES in Regulating Luminal Acidification in Rat Epididymis
por: Feng, Xiao, et al.
Publicado: (2020)